Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.62 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.61 |
| ▸ | NAAA | Q02083 | 1/20 | 0.58 |
| ▸ | EPHX1 | P07099 | 7/20 | 0.57 |
| ▸ | FAAH | O00519 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.48 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31620140 | 1.00 | CASP2 (0.62) | CASP2DNM1NAAAEPHX1FAAH | |
| SCHEMBL29312927 | 1.00 | CASP2 (0.62) | CASP2DNM1NAAAEPHX1FAAH | |
| SCHEMBL1826713 | 1.00 | CASP2 (0.62) | CASP2DNM1NAAAEPHX1FAAH | |
| SCHEMBL18871729 | 1.00 | CASP2 (0.62) | CASP2DNM1NAAAEPHX1FAAH | |
| SCHEMBL31620138 | 1.00 | CASP2 (0.62) | CASP2DNM1NAAAEPHX1FAAH | |
| SCHEMBL18402599 | 1.00 | CASP2 (0.62) | CASP2DNM1NAAAEPHX1FAAH | |
| SCHEMBL13123173 | 1.00 | CASP2 (0.62) | CASP2DNM1NAAAEPHX1FAAH | |
| Hydrochloric Acid SCHEMBL11416125 | 0.98 | CASP2 (0.60) | CASP2DNM1NAAAEPHX1FAAH | |
| SCHEMBL13970681 | 0.92 | DNM1 (0.55) | CASP2DNM1NAAAEPHX1FAAH | |
| SCHEMBL1828419 | 0.92 | MEN1 (0.52) | CASP2DNM1NAAAEPHX1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9155914-B2 | Composition for external application to skin | KAO CORPORATION (JP) | 2015-10-13 | — | — | US | disclosed |
| US-9155914-B2 | Composition for external application to skin | KAO CORPORATION (JP) | 2015-10-13 | — | — | US | disclosed |
| US-20100273875-A1 | Composition for External Application to Skin | KAO CORPORATION (JP) | 2010-10-28 | — | — | US | disclosed |
| US-20100273875-A1 | Composition for External Application to Skin | KAO CORPORATION (JP) | 2010-10-28 | — | — | US | disclosed |
| US-20070111923-A1 | SULFURIC ACID AMINE SALT, SULFONIC ACID AMINE SALT, PRODUCTION THEREOF AND SOFTENER COMPOSITION | KONO JUN | 2007-05-17 | — | — | US | disclosed |
| US-20070111923-A1 | SULFURIC ACID AMINE SALT, SULFONIC ACID AMINE SALT, PRODUCTION THEREOF AND SOFTENER COMPOSITION | KONO JUN | 2007-05-17 | — | — | US | disclosed |
| US-7179783-B2 | Sulfuric acid amine salt, sulfonic acid amine salt, production thereof and softener composition | KAO CORPORATION (JP) | 2007-02-20 | — | — | US | disclosed |
| US-7179783-B2 | Sulfuric acid amine salt, sulfonic acid amine salt, production thereof and softener composition | KAO CORPORATION (JP) | 2007-02-20 | — | — | US | disclosed |
| US-20060116314-A1 | Sulfuric acid amine salt, sulfonic acid amine salt, production thereof and softener composition | KONO JUN | 2006-06-01 | — | — | US | disclosed |
| US-20040023831-A1 | Sulfuric acid amine salt, sulfonic acid amine salt, production thereof and softener composition | KAO CORPORATION (JP) | 2004-02-05 | — | — | US | disclosed |
| EP-1354872-A1 | Sulfuric acid ester amine salts, sulfonic acid amine salts, production thereof and softener composition | KAO CORPORATION (JP) | 2003-10-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100273875-A1 | Composition for External Application to Skin | CUTA, COL14A1, COL2A1 | CASP2 4516/4885DNM1 3572/4885NAAA 2198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.